关键生物标志物与I型麻风反应最佳药物治疗方案之间定量相关性的研究
A Study of Quantitative Correlations Between Crucial Bio-markers and the Optimal Drug Regimen of Type-I Lepra Reaction
AI总结:
本文构建11室模型分析I型麻风反应中关键细胞因子等生物标志物与利福平、氯法齐明和氨苯砜MDT最佳剂量的定量关系,发现最优控制结果与WHO指南剂量基本一致。
摘要:
麻风病(Hansen病)是一种由麻风分枝杆菌引起的疾病。该病会缓慢导致麻风反应的发生,这些反应主要损害周围神经系统,从而造成器官丧失。我们可以通过监测与麻风反应相关的生物标志物来预防其发生。受这些观察结果的启发,在本研究工作中,我们开展了一项详尽研究,探讨关键生物标志物与用于治疗I型麻风反应的多重药物治疗(MDT)之间的定量相关性。我们构建并研究了一个复杂的11室模型,涉及血浆浓度$c_1(t)$和有效药物作用$c_2(t)$、易感雪旺细胞$S(t)$、受感染雪旺细胞$I(t)$、细菌载量$B(t)$,以及在I型麻风反应中起关键作用的五种细胞因子:IFN-$γ$、TNF-$α$、IL-$10$、IL-$12$、IL-$15$和IL-$17$。我们详尽探索并确立了利福平、氯法齐明和氨苯砜等MDT药物的最佳给药剂量与I型麻风反应所涉关键生物标志物之间的定量相关性。我们在结束本工作时重申了一个事实:通过这些最优控制研究得到的MDT药物最佳给药剂量,与按照WHO指南开具的剂量几乎相同。
英文摘要:
Leprosy (Hansen's) is a disease caused by Mycobacterium leprae. This disease slowly leads to occurrence of leprae reactions which mainly damage peripheral nervous system which cause loss of organs. We can prevent occurring leprae reactions by monitoring the bio-markers involved in it. Motivated by these observations in this research work we do a exhaustive study dealing with the quantitative correlations between crucial bio-markers and the Multi Drug Thearphy (MDT) used in treating the type I lepra reaction. We frame and study a complex 11 compartment model dealing with the the concentrations of plasma $c_1(t)$ and effective drug action $c_2(t)$, susceptible schwann cells $S(t)$, infected schwann cells $I(t)$, bacterial load $B(t)$, and five cytokines pivotal in Type-1 Lepra reaction: IFN-$γ$, TNF-$α$, IL-$10$, IL-$12$, IL-$15$, and IL-$17$. We explore exhaustively and establish the quantitative correlations with respect to the optimal drug dosage of the MDT drugs such as rifampin, clofazimine \& dapsone and the crucial bio-markers involved in type I lepra reaction. We conclude this work by reitrating the fact that the optimal drug dosage of the MDT drugs found through these optimal control studies and the dosage prescribed as per WHO guidelines are almost the same.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。